Middle East And Africa Diabetes Devices Market Size, Share & Trends Analysis Report By Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others), By Application (Hospitals, Homecare, Diagnostics Centers) and By Country (UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Rest of MEA) Forecasts, 2025-2033

Middle East and Africa Diabetes Devices Market Size and Growth Analysis

The Middle East and Africa diabetes devices market size was valued at USD 1,174.24 million in 2025 and is projected to grow from USD 1,261.13 million in 2026 to USD 2,232.51 million by 2034 at a CAGR of 7.4% during the forecast period 2026–2034.

Diabetes occurs when the pancreas is unable to produce insulin from the blood. Increased blood sugar levels induce untreated diabetes. Diabetes drugs are used to treat diabetes in particular. The purpose of diabetic treatment is to raise blood glucose levels. Diabetes care gadgets are used to monitor blood glucose levels in diabetics. A continuous glucose monitor (CGM) is a medical device that tracks and monitors the blood glucose levels of diabetes patients throughout the day. This wearable device will benefit those with diabetes since it can help them manage their glucose levels. Diabetic monitoring equipment includes ketone metres, blood glucose metres, continuous glucose metres, insulin pumps, smart insulin pens, and diabetes management software. Glucose monitoring devices help patients maintain and control their glucose levels, improving their health.

In the Middle East and Africa, self-monitoring with a glucometer is more acceptable due to the high costs involved with continuous glucose monitoring (CGM). These devices aid in the early detection of hypoglycemia and hyperglycemia, which drive the glucose monitoring industry.

Market Dynamics

Market Drivers

Lazy Lifestyle and Food Habits

Increased calorie consumption (high-fat diet) and lack of exercise, as well as genetic and environmental factors, all have a role in sugar level regulation in type 2 diabetes. All of these variables contribute to insulin-related issues, which lead to late-onset type 2 diabetes. With these factors, the number of people with diabetes will increase, and the demand for these devices will also increase.

Awareness about Diabetes Care

People nowadays are more aware of and concerned about diabetes and its implications and the case in same in the Middle East and Africa countries. Although, in some African countries of Africa there is still scope for increasing literacy and awareness still this increasing or rising awareness about diabetes care will enhance the demand for these devices.

Key Market Restraints

Low Medical Literacy Rate and Awareness

A large portion of the population in the Asia Pacific region comes from rural areas, where illiteracy rates are extremely high, as well as the level, quality, and awareness of medical facilities. As a result, many people are unaware of these devices and even of this disease, which may stymie market growth in this region.

High Cost of Medical Devices

It is a well-known fact that many African countries are economically not stable and still trying to get develop. Per capita income in many of the African countries is not enough and hence diabetic devices are not affordable easily for a significant proportion of the population which can serve as a restraint for the market growth in the African region

Middle East and Africa Diabetes Devices Market Segmentation Analysis

By Type

Blood glucose monitoring devices hold a strong position in the Middle East and Africa diabetes devices market because regular glucose testing is essential for effective diabetes management. The segment includes traditional glucose meters, test strips, lancets, and continuous glucose monitoring systems. Demand is supported by the increasing need for early diagnosis, routine monitoring, and improved control of blood sugar levels. Greater awareness of diabetes complications, expanding screening programs, and growing adoption of connected monitoring solutions are encouraging patients and healthcare providers to use accurate and convenient glucose monitoring technologies.

Insulin delivery devices include insulin pens, pumps, syringes, needles, and related accessories designed to support controlled insulin administration. Demand for these products is rising as patients seek safer, more convenient, and less painful treatment methods. Reusable and disposable insulin pens remain practical options, while connected pens and insulin pumps offer improved dose tracking and personalized therapy. Adoption varies across the region because of differences in affordability, insurance coverage, medical infrastructure, and patient education. Product availability and professional training also influence the use of advanced delivery systems.

By Distribution Channel

Online pharmacies are emerging as a rapidly expanding distribution channel due to increasing internet access, smartphone adoption, and consumer preference for convenient home delivery. These platforms allow patients to purchase glucose meters, test strips, lancets, pen needles, and other diabetes supplies without repeatedly visiting physical outlets. Subscription services and automated refill options can also support uninterrupted disease management. Growth is further encouraged by expanding digital payment systems, broader product comparison, discreet purchasing, and the development of regulated e-pharmacy services across several Middle Eastern and African markets.

Hospital pharmacies remain important because they provide prescribed diabetes devices to patients receiving inpatient and outpatient treatment. Retail pharmacies offer accessible purchasing points for routine monitoring products and replacement supplies, particularly in urban areas. Diabetes clinics and specialized centers support device selection, patient training, and treatment monitoring under professional supervision. Other channels include medical equipment suppliers, public health programs, distributors, and community-based healthcare organizations. Their market role depends on local healthcare structures, procurement systems, product availability, reimbursement conditions, and the ability to reach underserved or remote populations.

By Application

Hospitals represent a major application area for diabetes devices because they manage emergency cases, surgical patients, newly diagnosed individuals, and people experiencing serious diabetes-related complications. Healthcare professionals use glucose monitoring and insulin delivery products to maintain accurate glycemic control across intensive care units, general wards, and outpatient departments. Demand is supported by expanding hospital capacity, better diabetes screening, and the adoption of standardized treatment protocols. Hospitals also play an important role in educating patients about proper device operation before they continue treatment outside clinical settings.

Home care is gaining importance as portable and user-friendly devices allow patients to monitor glucose levels and administer insulin independently. Connected meters, continuous monitoring systems, mobile applications, and smart insulin devices help users follow treatment routines and share information with healthcare professionals. Diagnostic centers support diabetes screening, confirmation, and periodic assessment, particularly for people at risk of developing the condition. Demand across these applications is influenced by preventive healthcare programs, telemedicine adoption, patient education, affordability, and the availability of trained professionals who can interpret results and guide treatment.

Request Customizationto receive a tailored report.

Speak to an Analystto discuss market opportunities.

Regional Analysis

During the projected period, the Middle East And Africa Diabetes Devices Market is expected to increase at a CAGR of 7.4 %, reaching a total value of 1,765 million USD in 2030. In the Middle East and Africa, self-monitoring with a glucometer is more acceptable due to the high costs involved with continuous glucose monitoring (CGM). These devices aid in the early detection of hypoglycaemia and hyperglycaemia, which drive the glucose monitoring industry. Test strips account for 45% of the market in the Middle East and Africa, generating USD 136 million in revenue. When purchasing blood glucose test strips, the cost is typically a major consideration. Although some nations fund prescription test strips, the vast majority of patients must pay for them out of cash. Over the last decade, the number of diabetic patients in Africa has increased. Africa's total diabetes-related health spending is close to USD 9,500 million, with the figure predicted to nearly treble by 2045.

In the Middle East and Africa Blood Glucose Monitoring Market, Saudi Arabia and Iran together accounted for more than half of the market. Saudi Arabia has a 36% market share in the Middle East and Africa Blood Glucose Monitoring Market, followed by Iran and others. The rising prevalence of diabetes in Saudi Arabia has resulted in increased sales of blood glucose monitoring devices. Saudi Arabia has a high diabetes prevalence, with 24%, Kuwait at 23%, Bahrain at 22%, Qatar at 20%, and the United Arab Emirates at 19%. Israel is also experiencing encouraging growth in the market growth is the past few years due to increasing in the diabetic population in the market and increased awareness than before.

List of Key and Emerging Players in Middle East And Africa Diabetes Devices Market

• Medtronic
• Dexcom
• Johnson & Johnson
• Hoffmann-La Roche AG
• Abbott